CR10970A - Proceso e intermediarios para preparar arzoxifeno - Google Patents
Proceso e intermediarios para preparar arzoxifenoInfo
- Publication number
- CR10970A CR10970A CR10970A CR10970A CR10970A CR 10970 A CR10970 A CR 10970A CR 10970 A CR10970 A CR 10970A CR 10970 A CR10970 A CR 10970A CR 10970 A CR10970 A CR 10970A
- Authority
- CR
- Costa Rica
- Prior art keywords
- prepare
- arzoxifen
- intermediaries
- arzoxifene
- ch2ch3
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invencion proporciona nuevos compuestos de la formula I: en donde X es S o S(O); R1 y R2 se seleccionan cada uno independientemente del grupo que consiste de CH2CH3 y fenilo; o R1 y R2 se combinan para formar morfolino y con procesos para preparar arzoxifeno.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89515407P | 2007-03-16 | 2007-03-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR10970A true CR10970A (es) | 2009-11-02 |
Family
ID=39535578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR10970A CR10970A (es) | 2007-03-16 | 2009-08-06 | Proceso e intermediarios para preparar arzoxifeno |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8124776B2 (es) |
| EP (1) | EP2125774A1 (es) |
| JP (1) | JP2010521475A (es) |
| KR (1) | KR20090112758A (es) |
| AR (1) | AR065770A1 (es) |
| AU (1) | AU2008229183A1 (es) |
| BR (1) | BRPI0808740A2 (es) |
| CA (1) | CA2681478A1 (es) |
| CL (1) | CL2008000753A1 (es) |
| CR (1) | CR10970A (es) |
| DO (1) | DOP2009000218A (es) |
| EA (1) | EA200970863A1 (es) |
| EC (1) | ECSP099630A (es) |
| IL (1) | IL199785A0 (es) |
| MX (1) | MX2009009858A (es) |
| PE (1) | PE20081886A1 (es) |
| TN (1) | TN2009000372A1 (es) |
| TW (1) | TW200902521A (es) |
| WO (1) | WO2008115686A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2671516T3 (es) | 2013-02-19 | 2018-06-06 | Novartis Ag | Derivados de benzotiofeno y composiciones de los mismos como degradantes selectivos de los receptores de estrógeno |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG64896A1 (en) | 1995-02-28 | 1999-05-25 | Lilly Co Eli | Benzothiophene compounds intermediates compositions and methods |
| US5939439A (en) * | 1996-12-30 | 1999-08-17 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| ZA982877B (en) | 1997-04-09 | 1999-10-04 | Lilly Co Eli | Treatment of central nervous system disorders with selective estrogen receptor modulators. |
-
2008
- 2008-03-03 WO PCT/US2008/055626 patent/WO2008115686A1/en not_active Ceased
- 2008-03-03 KR KR1020097019225A patent/KR20090112758A/ko not_active Ceased
- 2008-03-03 BR BRPI0808740-7A patent/BRPI0808740A2/pt not_active IP Right Cessation
- 2008-03-03 EA EA200970863A patent/EA200970863A1/ru unknown
- 2008-03-03 JP JP2009553684A patent/JP2010521475A/ja not_active Withdrawn
- 2008-03-03 CA CA002681478A patent/CA2681478A1/en not_active Abandoned
- 2008-03-03 EP EP08731223A patent/EP2125774A1/en not_active Withdrawn
- 2008-03-03 MX MX2009009858A patent/MX2009009858A/es not_active Application Discontinuation
- 2008-03-03 US US12/526,657 patent/US8124776B2/en not_active Expired - Fee Related
- 2008-03-03 AU AU2008229183A patent/AU2008229183A1/en not_active Abandoned
- 2008-03-13 TW TW097108902A patent/TW200902521A/zh unknown
- 2008-03-14 CL CL200800753A patent/CL2008000753A1/es unknown
- 2008-03-14 AR ARP080101083A patent/AR065770A1/es unknown
- 2008-03-14 PE PE2008000481A patent/PE20081886A1/es not_active Application Discontinuation
-
2009
- 2009-07-09 IL IL199785A patent/IL199785A0/en unknown
- 2009-08-06 CR CR10970A patent/CR10970A/es not_active Application Discontinuation
- 2009-09-11 TN TNP2009000372A patent/TN2009000372A1/fr unknown
- 2009-09-14 EC EC2009009630A patent/ECSP099630A/es unknown
- 2009-09-15 DO DO2009000218A patent/DOP2009000218A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2125774A1 (en) | 2009-12-02 |
| ECSP099630A (es) | 2009-10-30 |
| CA2681478A1 (en) | 2008-09-25 |
| KR20090112758A (ko) | 2009-10-28 |
| DOP2009000218A (es) | 2009-09-30 |
| BRPI0808740A2 (pt) | 2014-08-12 |
| US8124776B2 (en) | 2012-02-28 |
| US20100137602A1 (en) | 2010-06-03 |
| JP2010521475A (ja) | 2010-06-24 |
| TN2009000372A1 (en) | 2010-12-31 |
| EA200970863A1 (ru) | 2010-02-26 |
| IL199785A0 (en) | 2010-04-15 |
| MX2009009858A (es) | 2009-10-20 |
| AU2008229183A1 (en) | 2008-09-25 |
| CL2008000753A1 (es) | 2008-09-26 |
| TW200902521A (en) | 2009-01-16 |
| AR065770A1 (es) | 2009-07-01 |
| WO2008115686A1 (en) | 2008-09-25 |
| PE20081886A1 (es) | 2008-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP10010129A (es) | Inhibidores de quinasas símil polo | |
| UY32098A (es) | Heteroarilos sustituidos | |
| CR10136A (es) | Nucleósidos antivirales | |
| ATE517107T1 (de) | Pyrrolopyrazinkinaseinhibitoren | |
| BR112012024117A2 (pt) | inibidores de pirrolopirazina quinase | |
| AR074021A1 (es) | Compuestos heterociclicos fusionados como moduladores del canal ionico | |
| UY31830A (es) | Activadores de glucoquinasa | |
| EA201590943A1 (ru) | Замещенные нуклеозиды, нуклеотиды и их аналоги | |
| CR11757A (es) | Compuestos de triazina como inhibidores mtor y quinasa pi3 | |
| ECSP099465A (es) | Polimorfos de sal de succinato 2-[6-(3-amino-piperidin-1-ilo)-3-metil-2,4-dioxo-3,4-dihidro-2h-pirimidin-1-ilmetil]-4-fluoro-benzonitrilo y métodos | |
| DOP2006000169A (es) | Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
| DK2250172T3 (da) | Pyrrolopyrazinkinaseinhibitorer | |
| DOP2011000050A (es) | Inhibidores de cmet | |
| UY32859A (es) | Compuestos y composiciones como inhibidores de cinasa de proteina | |
| GEP20146072B (en) | New compounds | |
| BR112012029647A2 (pt) | novos derivados de pirimidinas | |
| UY30371A1 (es) | Compuestos quimicos | |
| ATE522534T1 (de) | Pyrrolopyrazin-kinasehemmer | |
| MA38982A1 (fr) | Nouvel octahydro-cyclobuta [1,2-c; 3,4-c'] dipyrrol-2-yl | |
| AR074481A1 (es) | Derivados de tienopiridina como inhibidores de quinasa | |
| ECSP12011691A (es) | Compuestos de urea que contienen heteroarilo 5,6-bicíclicos como inhibidores de quinasa | |
| UY31750A (es) | Compuestos y composiciones como inhibidores de quinasa | |
| ECSP099315A (es) | Inhibidores de cinasa | |
| CL2013003056A1 (es) | Compuestos derivados de (fenil o piridin)-etinil-(piridin o pirimidin) sustituido; composición farmacéutica que los comprende; proceso de preparación de esto; y su uso en el tratamiento de la esquizofrenia o enfermedades cognitivas. | |
| UY30545A1 (es) | Derivados sustituidos del acido acilamino-benzoico, composiciones que los contienen y aplicaciones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |